November 2022 FDA Watch: Pace of New Approvals Slows
Though there were fewer new approvals last month, the impact of the products that did gain approval more than made up for the drop in volume.
Though there were fewer new approvals last month, the impact of the products that did gain approval more than made up for the drop in volume.
Research offers new evidence that a test targeting blood-based biomarkers can predict someone’s risk of developing long COVID.
The pandemic came with great pain and suffering for many, but it also allowed telehealth and other technologies to flourish.
The agency recently announced subtle but significant changes to its policies governing review of new lab tests for COVID-19.
Learn more about the legal remedies potentially available to clinical labs who have not been fully paid for COVID testing by insurers.